Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | DYE103K23I |
InChI Key | AUBPMADJYNSPOA-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C10H12N2 |
Molecular Weight | 160.22 |
AlogP | 2.05 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 25.25 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 12.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor alpha subunit
|
4200 | - | - | 32-58 | - | |
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor beta subunit
|
4200 | - | - | 32-67 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Schizophrenia | 2 | D012559 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 80787 |
ChEMBL | CHEMBL1230982 |
EPA CompTox | DTXSID50188266 |
FDA SRS | DYE103K23I |
KEGG | C16906 |
PDB | AN4 |
PubChem | 18985 |
SureChEMBL | SCHEMBL261062 |
ZINC | ZINC000014722833 |